These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24634219)

  • 1. A novel small-molecule tumor necrosis factor α inhibitor attenuates inflammation in a hepatitis mouse model.
    Ma L; Gong H; Zhu H; Ji Q; Su P; Liu P; Cao S; Yao J; Jiang L; Han M; Ma X; Xiong D; Luo HR; Wang F; Zhou J; Xu Y
    J Biol Chem; 2014 May; 289(18):12457-66. PubMed ID: 24634219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of a small molecule indole analog, 1-[(1H-indol-3-yl)methylene]-2-phenylhydrazine (HMPH), in chronic inflammation.
    Misra CS; Gejjalagere Honnappa C; Jitta SR; Gourishetti K; Daram P; Singh MP; Hosur Shrungeswara A; Nayak Y; Unnikrishnan MK
    Chem Biol Interact; 2016 Jan; 244():71-83. PubMed ID: 26549477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.
    Mouhsine H; Guillemain H; Moreau G; Fourati N; Zerrouki C; Baron B; Desallais L; Gizzi P; Ben Nasr N; Perrier J; Ratsimandresy R; Spadoni JL; Do H; England P; Montes M; Zagury JF
    Sci Rep; 2017 Jun; 7(1):3424. PubMed ID: 28611375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of highly potent TNFα inhibitors using virtual screen.
    Shen Q; Chen J; Wang Q; Deng X; Liu Y; Lai L
    Eur J Med Chem; 2014 Oct; 85():119-26. PubMed ID: 25078315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor.
    Sun W; Wu Y; Zheng M; Yang Y; Liu Y; Wu C; Zhou Y; Zhang Y; Chen L; Li H
    J Med Chem; 2020 Aug; 63(15):8146-8156. PubMed ID: 32667202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1.
    Steeland S; Puimège L; Vandenbroucke RE; Van Hauwermeiren F; Haustraete J; Devoogdt N; Hulpiau P; Leroux-Roels G; Laukens D; Meuleman P; De Vos M; Libert C
    J Biol Chem; 2015 Feb; 290(7):4022-37. PubMed ID: 25538244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
    Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
    FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preferential p110alpha/gamma PI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-kappaB-dependent manner.
    Dagia NM; Agarwal G; Kamath DV; Chetrapal-Kunwar A; Gupte RD; Jadhav MG; Dadarkar SS; Trivedi J; Kulkarni-Almeida AA; Kharas F; Fonseca LC; Kumar S; Bhonde MR
    Am J Physiol Cell Physiol; 2010 Apr; 298(4):C929-41. PubMed ID: 20089935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.
    Kunisch E; Gandesiri M; Fuhrmann R; Roth A; Winter R; Kinne RW
    Ann Rheum Dis; 2007 Aug; 66(8):1043-51. PubMed ID: 17223661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Ligands for TNF-α and TNF Receptor-1 through Structure-Based Virtual Screening and Biological Assay.
    Chen S; Feng Z; Wang Y; Ma S; Hu Z; Yang P; Chai Y; Xie X
    J Chem Inf Model; 2017 May; 57(5):1101-1111. PubMed ID: 28422491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.
    Mourey RJ; Burnette BL; Brustkern SJ; Daniels JS; Hirsch JL; Hood WF; Meyers MJ; Mnich SJ; Pierce BS; Saabye MJ; Schindler JF; South SA; Webb EG; Zhang J; Anderson DR
    J Pharmacol Exp Ther; 2010 Jun; 333(3):797-807. PubMed ID: 20237073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor receptor-1 can function through a G alpha q/11-beta-arrestin-1 signaling complex.
    Kawamata Y; Imamura T; Babendure JL; Lu JC; Yoshizaki T; Olefsky JM
    J Biol Chem; 2007 Sep; 282(39):28549-28556. PubMed ID: 17664271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in tumor necrosis factor (TNF)alpha and TNF receptor-1-mediated intracellular signaling factors in normal, inflamed and scar-formed horse tendons.
    Hosaka Y; Kirisawa R; Ueda H; Yamaguchi M; Takehana K
    J Vet Med Sci; 2005 Oct; 67(10):985-91. PubMed ID: 16276053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis.
    Arshad MI; Piquet-Pellorce C; L'Helgoualc'h A; Rauch M; Patrat-Delon S; Ezan F; Lucas-Clerc C; Nabti S; Lehuen A; Cubero FJ; Girard JP; Trautwein C; Samson M
    Hepatology; 2012 Dec; 56(6):2353-62. PubMed ID: 22961755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling.
    Mirando AC; Lima E Silva R; Chu Z; Campochiaro PA; Pandey NB; Popel AS
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1).
    Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
    J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.
    Miwatashi S; Arikawa Y; Kotani E; Miyamoto M; Naruo K; Kimura H; Tanaka T; Asahi S; Ohkawa S
    J Med Chem; 2005 Sep; 48(19):5966-79. PubMed ID: 16162000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
    Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
    J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.